Welcome to Medications.com

Par Pharmaceutical Swings to 4Q Profit - Forbes

... of FineTech Laboratories, Ltd. and a $9.2 million asset impairment charge related to Par's purchase of the new drug application for Isoptin SR. ...

http://www.forbes.com/feeds/ap/20... | Posted: Thu Sep 06 15:36:17 -0400 2007




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea